DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Van Gaal LF, Scheen AJ, Rissanen AM, Rossner S, Hanotin C, Ziegler O.
Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.
Eur Heart J 2008; 29: 1761-1771
We do not assume any responsibility for the contents of the web pages of other providers.